Korea Omega Investment

Korea Omega Investment is a private equity and venture capital firm established in 2015 and located in Seoul, South Korea. The firm focuses on identifying and investing in promising companies both domestically and internationally. With a commitment to fostering innovation and growth, Korea Omega Investment aims to support the development of high-potential businesses across various sectors.

Won Lee

Senior Vice President

Jeong Oh Shin

Managing Director

36 past transactions

MilieMoon

Seed Round in 2024
MilieMoon is a global jewelry brand that specializes in offering semi-fine jewelry with a handpicked selection.

Crosspoint Therapeutics

Seed Round in 2024
CrossPoint Therapeutics is a therapeutics company focused on drug development, utilizing its proprietary Stealth-Body technology, which is based on antibody sources. This innovative approach aims to enhance the effectiveness of therapeutic agents in treating various medical conditions. By leveraging advanced scientific techniques, CrossPoint Therapeutics seeks to create novel treatments that improve patient outcomes and address unmet medical needs.

Urban Labs

Seed Round in 2023
Urban Labs is a food technology company focused on developing plant-based protein alternatives by utilizing coffee grounds, a by-product of coffee production. By leveraging artificial intelligence and big data, the company conducts research to create innovative food products that provide sustainable protein options. Urban Labs aims to offer consumers scientifically developed alternatives that contribute to environmental sustainability while addressing the growing demand for plant-based diets.

DeepSmartech

Seed Round in 2023
DeepSmartech is a developer of polymer nano-coating technologies that specializes in providing precise, functional coatings for various products. The company focuses on room-temperature polymer nano-coating, enabling the application of coatings with specific thicknesses over large surface areas. DeepSmartech offers comprehensive consultancy and manufacturing support services, guiding businesses through the entire process of equipment, processes, and materials required for product development. By leveraging its advanced technology, the company aims to enhance performance and address technical challenges, particularly in the semiconductor and lithium-ion battery sectors.

Estate Cloud

Seed Round in 2022
Estate Cloud offers online real estate services focused on facilitating the buying and selling of properties. The company has developed a real estate information application that delivers optimized brokerage services. This application enables users to access comprehensive real estate listings for both buyers and sellers and features an automated brokerage system. By utilizing this technology, Estate Cloud allows users to efficiently search for properties and connect with potential buyers or sellers based on their specific needs.

Colley

Series A in 2022
Colley is an online platform that specializes in creating and selling intellectual property products related to theme parks. The platform offers users a space to showcase their interests and preferences, facilitating the exchange of information about entertainment products. By allowing individuals to demonstrate their virtues and tastes, Colley enhances the purchasing experience, enabling users to make more informed decisions. Through its innovative approach, Colley aims to connect consumers with products that resonate with their personal values and interests.

Caring

Series A in 2022
Caring is a visiting medical treatment facility that offers medical consultation.

Stickybomb

Seed Round in 2022
Trineedle operates a live-streaming platform designed to connect creators and their audiences. This platform allows viewers to interact with creators in real-time, enhancing the streaming experience by enabling the use of meme stickers that can be attached to the broadcast screen. This interactive feature fosters a sense of community and engagement, allowing both creators and viewers to share and enjoy the live stream collaboratively. Through its innovative approach, Trineedle aims to enrich the live-streaming experience by bridging the gap between creators and fans.

Point2

Series B in 2022
Point2 Technology, founded in 2016 and based in Seoul, South Korea, specializes in developing advanced connectivity solutions aimed at meeting the growing bandwidth demands of 5G and cloud-based data centers. The company focuses on creating dielectric waveguide technology that enables high-speed, short-range interconnectivity. Its products are designed to deliver reliable, low-cost, and low-power solutions, facilitating efficient point-to-point connections for data center applications. By addressing the critical needs of modern infrastructure, Point2 Technology positions itself as a key player in enhancing data connectivity for the future.

Y-Biologics

Venture Round in 2022
Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a unique bispecific antibody platform technology known as AliCE, which retains the structure of the parental antibody to ensure high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL library, which comprises a diverse range of antibodies. The company also offers contract research services, further contributing to its position in the antibody drug market. Through its innovative technologies and research efforts, Y-Biologics aims to advance its portfolio of antibody drugs and strengthen its role in the global immuno-chemotherapeutic landscape.

Jobis

Venture Round in 2022
Jobis is an accounting management platform by AI.

Boosters

Series A in 2022
Boosters is a brand aggregator that uncovers and acquires high-potential brands that have been hidden for a long time, or discovers commerce businesses that will be appreciated by the public at an early stage. They achieve scale-up by developing tactics that are specific to each brand's attributes. Scale-up is the maximum of sales for Boosters.

Sellerhub

Series B in 2021
Imagine if you are the online seller, having to sign up and upload your products to 30+ different major commerce websites to maximize your sales. Sellerhub is a web-based commerce suite of solutions where you as the seller sign up, create your online shop, upload product information ONCE then it will be transferred/synched on up to 30+ different major commerce websites at the same time and allow you to manage all their orders in a single integrated dashboard. From building your online shop front, expanding commerce channels, as well as integrating marketing/ad and fulfillment operations, Sellerhub is a one-stop solution for online sellers to manage ALL of your commerce activities in a single dashboard. Key Benefits: 1. Create and manage a beautiful, fully customizable Flagship store online. 2. Single product upload, API-transfer up to 30+ major commerce websites and begin selling simultaneously 3. Fulfillment, Dropshipping, and professional services are also available for you to choose from the full suite of solutions, either directly or through partnership program Established in 2012 with accrued GMV of 1.2 Billion USD, Sellerhub offers a full suite of solutions & services that empower online seller's selling activities, helping you grow revenue and reduce cost/time managing.

Aardvark Therapeutics

Series B in 2021
Aardvark Therapeutics, Inc. is a biopharmaceutical company based in San Diego, California, focused on developing and commercializing small molecule therapeutics for obesity and rare genetic metabolic disorders. Founded in 2017 by Tien Lee, the company has introduced Bittera, a first-in-class oral composition designed to selectively disrupt hunger signaling and regulate energy homeostasis. This innovative therapeutic approach provides clinicians with an effective and safe treatment option for obesity-related diseases, without interfering with nutrient absorption. Aardvark Therapeutics aims to address significant health challenges associated with obesity and metabolic conditions through its specialized drug development efforts.

FuriosaAI

Series B in 2021
FuriosaAI delivers the performance for real-time AI services while achieving energy efficiency for the lowest operation cost at scale. They build the entire product on a solid core foundation because AI chips on the ground are doomed to fail when it comes to addressing the complex and rapidly changing requirement metrics of hyper scalers and enterprises.

iN Therapeutics

Series A in 2021
iN Therapeutics is a biotechnology company focused on developing innovative drug therapies for patients with incurable neurological diseases. The company is engaged in the creation of treatments targeting various conditions, including non-narcotic analgesics for Nav1.7, hearing loss, and other brain-related disorders. By advancing its drug development pipeline, iN Therapeutics aims to provide effective solutions for central nervous system diseases, ultimately enhancing the quality of life for affected individuals.

Dalock

Series B in 2021
DaLock is a self-storage company that specializes in providing warehousing services to help clients manage their space and physical limitations. The company offers a range of services, including logistics, distribution storage, and warehouse areas, utilizing unused space to enhance the living and working environments of its customers. By addressing storage needs, DaLock aims to improve the quality of life for individuals and businesses alike.

Onegene Biotechnology

Series A in 2021
Onegene Biotechnology is a biotechnology company focused on developing innovative protein-based therapeutics aimed at treating cancer, metabolic, and inflammatory diseases. The company utilizes advanced protein conjugation technology, which involves the connection of separate proteins to create recombinant proteins through post-translational fusion. This approach enables the production of complex proteins with large molecular weights, facilitating the development of multispecific drugs that target multiple pathways simultaneously. Onegene's unique ability to combine various molecular types, including Fab fragments, scFv, sdAb, peptides, cytokines, and enzymes, allows for unprecedented design flexibility and optimized physical properties. Consequently, this innovation expands the potential for effective treatments for complex and multifactorial diseases, offering prolonged benefits for patients.

Jobis

Venture Round in 2021
Jobis is an accounting management platform by AI.

OKXE

Series A in 2020
Okxe is an online marketplace designed to facilitate the buying and selling of motorcycles. The platform connects motorcycle sellers and buyers, utilizing artificial intelligence and big data to enhance the shopping experience. It features a diverse selection of verified motorcycles from various brands and stores, ensuring a safe and efficient environment for customers. By providing an open market, Okxe aims to streamline the e-commerce process for motorcycle enthusiasts, allowing them to explore different options and make informed purchasing decisions.

Animal Industry Data Korea

Series A in 2020
Animal Industry Data Korea is a livestock healthcare solution provider company.

Aardvark Therapeutics

Series A in 2019
Aardvark Therapeutics, Inc. is a biopharmaceutical company based in San Diego, California, focused on developing and commercializing small molecule therapeutics for obesity and rare genetic metabolic disorders. Founded in 2017 by Tien Lee, the company has introduced Bittera, a first-in-class oral composition designed to selectively disrupt hunger signaling and regulate energy homeostasis. This innovative therapeutic approach provides clinicians with an effective and safe treatment option for obesity-related diseases, without interfering with nutrient absorption. Aardvark Therapeutics aims to address significant health challenges associated with obesity and metabolic conditions through its specialized drug development efforts.

FuriosaAI

Series A in 2019
FuriosaAI delivers the performance for real-time AI services while achieving energy efficiency for the lowest operation cost at scale. They build the entire product on a solid core foundation because AI chips on the ground are doomed to fail when it comes to addressing the complex and rapidly changing requirement metrics of hyper scalers and enterprises.

Pet Friends

Series B in 2019
Pet Friends is an online pet care platform that specializes in the rapid delivery of pet supplies. The company operates an innovative logistics and delivery system designed to meet the needs of pet owners, allowing them to receive essential products within one hour. In addition to its delivery services, Pet Friends provides consultations and free snack sampling tests, making it easier for busy pet owners to care for their pets. By streamlining access to pet-related products and services, Pet Friends enhances the overall pet ownership experience.

ADIntelligence

Seed Round in 2019
ADIntelligence develops ADVisor solution that provides integrated online marketing analytics and ad operations solutions.

Animal Industry Data Korea

Seed Round in 2018
Animal Industry Data Korea is a livestock healthcare solution provider company.

Genome

Series B in 2018
Genome & Company, headquartered in Seongnam, South Korea, specializes in researching microbes and probiotics to develop dietary supplements, cosmeceuticals, and novel drugs targeting conditions such as obesity, diabetes, acne, atopic dermatitis, and cancer-related therapies.

Juvic

Seed Round in 2018
Juvic specializes in the development of biodegradable microneedle technology aimed at enhancing drug delivery systems. Their innovative approach utilizes low-temperature fabrication and pillar transfer methodology, distinguishing it from traditional micro-molding processes. This technology allows for the transdermal delivery of drugs without pain, ensuring that active substances remain stable and effective by minimizing heat exposure during production. Juvic's microneedles provide medical practitioners with a convenient and efficient solution for administering medications.

Genome

Series A in 2017
Genome & Company, headquartered in Seongnam, South Korea, specializes in researching microbes and probiotics to develop dietary supplements, cosmeceuticals, and novel drugs targeting conditions such as obesity, diabetes, acne, atopic dermatitis, and cancer-related therapies.

Jobis

Series A in 2017
Jobis is an accounting management platform by AI.

Poing

Series B in 2017
Poing is a restaurant service platform that focuses on enhancing the dining experience for customers and streamlining management for restaurant owners. It offers an online search and reservation system, allowing diners to easily find and book tables at various establishments. Additionally, Poing provides a comprehensive suite of management solutions tailored for food service operators, combining practical guidance with offline content to support successful restaurant operations. By integrating these features, Poing aims to improve the overall efficiency and effectiveness of restaurant management while facilitating better dining choices for customers.

ODDM

Venture Round in 2016
ODDM is a South Korean company founded in 2011 by Musun Park and Soyeon An, specializing in online and mobile marketing solutions. The name ODDM reflects its mission to deliver unique and inventive mobile services. The company gained significant traction with the launch of Podgate, a portal for free iOS applications, and later introduced Adpick, an influencer marketing platform in 2013. Adpick allows social media users to earn income by promoting products from advertisers on their channels. This platform has been pivotal in shaping the Korean influencer marketing landscape, attracting both advertisers seeking organic engagement and influencers looking for revenue opportunities. As of September 2016, Adpick had facilitated approximately 1,400 ad campaigns and engaged around 500,000 influencers. Recognizing its growth potential and innovative ad technology, ODDM received investment from a Korean venture capital firm in April 2016. The company aims to enhance user satisfaction by focusing on quality services and plans to expand into the global market, beginning with an office in Tokyo, Japan.

IGAWorks

Series C in 2015
IGAWorks is a comprehensive ad-tech company established in 2006, specializing in services that enhance digital marketing and mobile business success. The company offers a range of solutions, including Tradingworks, an agency trade desk that delivers complete advertising services; adbrix, an integrated data platform that supports mobile business growth through ad performance and user data; and adPOPcorn, Korea's largest ad network. Additionally, IGAWorks provides Mobile Index, a platform for mobile app market analytics, and Campaign Intelligence, a reporting tool that significantly reduces the workload for marketers. With over 30,000 mobile applications leveraging its services, IGAWorks aims to optimize monetization and marketing strategies for publishers and businesses in the mobile sector.

VSI

Venture Round in 2000
VSI is a manufacturer of X-ray devices that are designed to enhance the quality and yield of the industrial manufacturing process. The company's devices incorporate carbon nanotubes and are utilized for various applications such as bone imaging, non-destructive inspection in industrial settings, and film imaging. These devices effectively prevent radiation leakage without the need for lead, ensuring safety. Moreover, they are user-friendly, featuring a simple user interface that allows clients to overcome the limitations of conventional corona discharge static eliminators.

Astrogen

Astrogen is a biotechnology company focused on developing innovative drugs to address challenging neurological diseases. The company engages in clinical research to create treatment alternatives for conditions such as autism spectrum disorder and Alzheimer's disease. Through its drug development efforts, Astrogen aims to provide medical professionals with effective options to assist patients suffering from irreversible neurological disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.